Editorial · 30 Apr 2026
EditorialPublished 30 Jun 2021
Approved Drugs from Marine Origin
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Cytarabine is the first anti-cancer medicine of marine origin to be commercially accessible. It's a pyrimidine nucleoside analogue that serves as a cytotoxic medication that targets the cell cycle specifically. It is most active during cell division's S phase, when the cells are undertaking DNA synthesis. The US Food and Drug Administration (FDA) approved cytarabine, which was marketed under the brand name Cytosar-U®. A staple medicine in the treatment of acute myeloid leukaemia, acute lymphoblastic leukaemia, and chronic myelogenous leukaemia is Cytosar-U®. Since then, further anti-cancer compounds derived from marine sources have been accessible. For example, the liposomal formulation CPX-351 (Vyxeos®) contains a 5:1 ratio of cytarabine and daunorubicin. When CPX-351 was delivered to the leukaemia cells of patients with secondary acute myeloid leukaemia, it resulted in a significant improvement in overall survival compared to the standard of care.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Marine Biology & Oceanography.
Editorial · 30 Apr 2026
EUTROPHICATION: DRIVERS IMPACTS AND MANAGEMENT OF NUTRIENT OVERLOAD
Editorial · 30 Apr 2026
COLD-ADAPTED SPECIES: ADAPTATIONS ECOLOGY AND CLIMATE CHANGE IMPLICATIONS
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Marine Biology & Oceanography
- SubjectEnvironmental & Earth Sciences
- SubjectGeology and Earth Science
- BylineArticles whose byline prints “Emma Griffin”

